Cargando…
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
Tamoxifen resistance is often observed in the majority of estrogen receptor–positive breast cancers and it remains as a serious clinical problem in breast cancer management. Increased aerobic glycolysis has been proposed as one of the mechanisms for acquired resistance to chemotherapeutic agents in...
Autores principales: | Woo, Yu Mi, Shin, Yubin, Lee, Eun Ji, Lee, Sunyoung, Jeong, Seung Hun, Kong, Hyun Kyung, Park, Eun Young, Kim, Hyoung Kyu, Han, Jin, Chang, Minsun, Park, Jong-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497721/ https://www.ncbi.nlm.nih.gov/pubmed/26158266 http://dx.doi.org/10.1371/journal.pone.0132285 |
Ejemplares similares
-
Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
por: Weng, Mei-lin, et al.
Publicado: (2020) -
Decreased Expression of MPC2 Contributes to Aerobic Glycolysis and Colorectal Cancer Proliferation by Activating mTOR Pathway
por: Kuerbanjiang, Manzila, et al.
Publicado: (2021) -
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma
por: Zhang, Hong, et al.
Publicado: (2022) -
FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
por: Díaz, Mario, et al.
Publicado: (2021) -
Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer
por: Zhang, Xiujuan, et al.
Publicado: (2022)